Evidence map›Paper›PMID 40703803›Full record

ArticleNeuro-oncology advances

Sociodemographic factors predict outcomes and reveal spatial tumor patterns in glioblastoma.

Patrick H Luckett, Michael Olufawo, Noah Naddaff-Slocum, Ki Yun Park, Bidhan Lamichhane, Donna Dierker, Gabriel Trevino Verastegui, John J Lee, Peter Yang, Albert Kim and 5 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Patrick H LuckettDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Michael OlufawoDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Noah Naddaff-SlocumDepartment of Biology, Washington University College of Arts and Sciences, St. Louis, Missouri, USA.
Ki Yun ParkDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Bidhan LamichhaneCenter for Health Sciences, Oklahoma State University, Tulsa, Oklahoma, USA.
Donna DierkerMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Gabriel Trevino VerasteguiDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
John J LeeMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Peter YangDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Albert KimDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Omar H ButtDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Milan G ChhedaDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Abraham Z SnyderDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Joshua S ShimonyMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Eric C LeuthardtNational Center for Adaptive Neurotechnologies, Albany, New York, USA.

Funding

Training and DisseminationP41EB018783 · NIBIB · WADSWORTH CENTER · PI Jonathan Saul Carp · 2014 to 2026
$15.4M
Augmented Neurosurgical Navigation Software Using Resting State MRIR01CA203861 · NCI · WASHINGTON UNIVERSITY · PI Eric CLAUDE Leuthardt, JOSHUA S SHIMONY · 2017 to 2026
$5.8M
BCI2000: Software Resource for Adaptive Neurotechnology ResearchU24NS109103 · NINDS · WASHINGTON UNIVERSITY · PI BRUNNER, PETER · 2019 to 2024
$2.8M
BCI2000+: A Software Platform for Adaptive NeurotechnologiesR01EB026439 · NIBIB · WASHINGTON UNIVERSITY · PI BRUNNER, PETER · 2018 to 2022
$1.5M
NCI NIH HHS R01 CA203861NIBIB NIH HHS P41 EB018783NIBIB NIH HHS R01 EB026439NINDS NIH HHS U24 NS109103
6 · The paper itself

Abstract

Background: Glioblastoma (GBM) is the deadliest malignant glioma of the central nervous system. Postsurgical functional impairment correlates with survival and is estimated using metrics such as extent and location of resection. This study uses machine learning to evaluate the predictive ability of baseline sociodemographic and lifestyle factors for forecasting postoperative functional outcomes in GBM patients. Methods: Glioblastoma patients ( Results: Utilizing decision trees with age, SVI/SES, sex, tobacco use, alcohol use, obesity, and race as predictors, we achieved 88% accuracy in classifying median KPS and 85% accuracy in classifying KPS slope. Socioeconomic factors were the strongest predictors. Age, sex, and tobacco use were also strong predictors. Significant correlations in spatial tumor distributions were observed based on outcome measures and SVI/SES. Conclusions: The current work demonstrates the utility of machine learning to predict functional outcomes in GBM patients prior to treatment using lifestyle and sociodemographic factors. Our results suggest that socioeconomic factors, age, tobacco use, and biological sex can be reliable predictors of functional outcomes. Incorporating these factors could improve therapeutic approaches tailored to individual patients.

Indexed as

brain tumorglioblastomamachine learningsociodemographic

Identifiers

PMID40703803
PMCPMC12284634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.